share_log

复星医药(02196.HK)8月27日举行董事会会议考虑及通过中期业绩

Fosun Pharma (02196.HK) held a board of directors meeting on August 27 to consider and approve interim performance.

Gelonghui Finance ·  Aug 12 05:10

Fosun Pharma (02196.HK) announced that the board of directors meeting will be held on August 27, 2024 (Tuesday) to consider and approve the interim performance of the company and its subsidiaries for the six months ended June 30, 2024, and to publish.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment